Abstract
Isotretinoin (13-cis-retinoic acid, 13cRA) has proven to be active in chemoprevention of head and neck squamous cell carcinoma (HNSCC). Moreover, both all- trans -retinoic acid (ATRA) and 13cRA induce objective responses in oral premalignant lesions. After binding of retinoids to retinoic acid receptors (RARs and RXRs) dimers are formed that are able to regulate the expression of genes involved in growth and differentiation. We compared the metabolism and level of growth inhibition of 13cRA with that of ATRA, 9cRA and retinol in four HNSCC cell lines and normal oral keratinocyte cultures (OKC). These retinoid compounds are known to bind with different affinities to the retinoic acid receptors. We observed that all retinoids were similar with respect to their capacity to induce growth inhibition. One HNSCC line could be ranked as sensitive, one as moderately sensitive and the remaining two were totally insensitive; OKC were moderately sensitive. The rate at which the cells were able to catabolize the retinoid was similar for all compounds. Retinoid metabolism in HNSCC cells resulted in a profile of metabolites that was unique for each retinoid. These metabolic profiles were different in OKC. Our findings indicate that differences in retinoid receptor selectivity of these retinoids do not influence the level of growth inhibition and rate of metabolism. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Allenby G, Bocquel MT, Saunders M, Kazmer S, Speck J, Rosenberger M, Lovey A, Kastner P, Grippo JF, Chambon P and Levin AE (1993) Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc Natl Acad Sci USA 90: 30–34
Armstrong WB and Meyskens FL Jr (2000) Chemoprevention of head and neck cancer. Otolaryngol Head Neck Surg 122: 728–735
Åström A, Pettersson U, Krust A, Chambon P and Voorhees JJ (1990) Retinoic acid and synthetic analogs differentially activate retinoic acid receptor dependent transcription. Biochem Biophys Res Commun 173: 339–345
Bhat PV, De Luca LM, Adamo S, Akalovsky I, Silverman-Jones CS and Peck GL (1979) Retinoid metabolism in spontaneously transformed mouse fibroblasts (Balb/c 3T12–3 cells): enzymatic conversion of retinol to anhydroretinol. J Lipid Res 20: 357–362
Bollag W and Holdener EE (1992) Retinoids in cancer prevention and therapy. Ann Oncol 3: 513–526
Braakhuis BJM, Jansen G, Noordhuis P, Kegel A and Peters GJ (1993) Importance of pharmacodynamics in the in vitro antiproliferative activity of the antifolates methotrexate and 10-ethyl-10-deazaaminopterin against human head and neck squamous cell carcinoma. Biochem Pharmacol 46: 2155–2161
Braakhuis BJM, Klaassen I, van der Leede BM, Cloos J, Brakenhoff RH, Copper MP, Teerlink T, Hendriks HF, van der Saag PT and Snow GB (1997) Retinoid metabolism and all-trans retinoic acid-induced growth inhibition in head and neck squamous cell carcinoma cell lines. Br J Cancer 76: 189–197
Carey TE, Wolf GT, Baker SR and Krause CJ (1990) Cell surface antigen expression and prognosis. Head and neck cancer Fee WE, Goephert H, Johns ME, Strong EW and Ward PH (eds) pp. 77–82, BC Decker: Toronto – Philadelphia
Dzerk AM, Carlson A, Loewen GR, Shirley MA and Lee JW (1998) A HPLC method for the determination of 9-cis retinoic acid (ALRT1057) and its 4-oxo metabolite in human plasma. J Pharm Biomed Anal 16: 1013–1019
Eckhoff C and Nau H (1990) Identification and quantitation of all-trans-and 13-cis-retinoic acid and 13-cis-4-oxoretinoic acid in human plasma. J Lipid Res 31: 1445–1454
Gudas LJ, Sporn MB and Roberts AB (1994) Cellular biology and biochemistry of the retinoids. The Retinoids Sporn MB, Roberts AB and Goodman DS (eds) pp. 443–520, Raven Press: New York
Guo X and Gudas LJ (1998) Metabolism of all-trans-retinol in normal human cell strains and squamous cell carcinoma (SCC) lines from the oral cavity and skin: reduced esterification of retinol in SCC lines. Cancer Res 58: 166–176
Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM and Thaller C (1992) 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68: 397–406
Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, Fofonoff S, Byers R, Atkinson EN and Vaughan C (1986) 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315: 1501–1505
Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, Dimery IW, Brown BW and Goepfert H (1990) Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 323: 795–780
Hong WK and Itri LM (1994) Retinoids and human cancer. The Retinoids Sporn MB, Roberts AB and Goodman DS (eds) pp. 597–630, Raven Press: New York
Klaassen I, Brakenhoff RH, Smeets SJ, Snow GB and Braakhuis BJ (1999) Considerations for in vitro retinoid experiments: importance of protein interaction. Biochem Biophys Acta 1427: 265–275
Klaassen I, Brakenhoff RH, Smeets SJ, Snow GB and Braakhuis BJ (2001a) Enhanced turnover of all-trans-Retinoic acid and increased formation of polar metabolites in head and neck squamous cell carcinoma cells compared to normal oral keratinocytes. Clin Cancer Res 7: 1017–1025
Klaassen I, Brakenhoff RH, Smeets SJ, Snow GB and Braakhuis BJ (2001b) The expression of retinoic acid receptor γ correlates with retinoic acid sensitivity and metabolism in head and neck squamous cell carcinoma cell lines. Int J Cancer 92: 661–665
Koch HF (1978) Biochemical treatment of precancerous oral lesions: the effectiveness of various analogues of retinoic acid. J Maxillofac Surg 6: 59–63
Kurlandsky SB, Duell EA, Kang S, Voorhees JJ and Fisher GJ (1996) Auto-regulation of retinoic acid biosynthesis through regulation of retinol esterification in human keratinocytes. J Biol Chem 271: 15346–15352
Le Q, Dawson MI, Soprano DR and Soprano KJ (2000) Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids. Oncogene 19: 1457–1465
Leo MA and Lieber CS (1985) New pathway for retinol metabolism in liver microsomes. J Biol Chem 260: 5228–5231
Lippman SM, Kessler JF, AI Sarraf M, Alberts DS, Itri LM, Mattox D, Von Hoff DD, Loescher L and Meyskens FL (1988) Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: a phase II randomized trial. Invest New Drugs 6: 51–56
Lotan R (1980) Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 605: 33–91
Mangelsdorf DJ (1994) Vitamin A receptors. Nutr Rev 52: S32–S44
Muindi JR, Young CW and Warrell RP Jr (1994) Clinical pharmacology of all-trans retinoic acid. Leukemia 8: S16–S21
Oridate N, Esumi N, Lotan D, Hong WK, Rochette-Egly C, Chambon P and Lotan R (1996) Implication of retinoic acid receptor gamma in squamous differentiation and response to retinoic acid in head and neck SqCC/Y1 squamous carcinoma cells. Oncogene 12: 2019–2028
Park SH, Gray WC, Hernandez I, Jacobs M, Ord RA, Sutharalingam M, Smith RG, Van Echo DA, Wu S and Conley BA (2000) Phase I trial of all-trans retinoic acid in patients with treated head and neck squamous carcinoma. Clin Cancer Res 6: 847–854
Raner GM, Vaz AD and Coon MJ (1996) Metabolism of all-trans, 9-cis, and 13-cis isomers of retinal by purified isozymes of microsomal cytochrome P450 and mechanism-based inhibition of retinoid oxidation by citral. Mol Pharmacol 49: 515–522
Ray WJ, Bain G, Yao M and Gottlieb DI (1997) CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new family. J Biol Chem 272: 18702–18708
Reid CB, Cloos J, Snow GB and Braakhuis BJ (1997) A simple and reliable technique for culturing of human oral keratinocytes and fibroblasts. Acta Otolaryngol 117: 628–633
Roberts AB, Lamb LC and Sporn MB (1980) Metabolism of all-trans-retinoic acid in hamster liver microsomes: oxidation of 4-hydroxy- to 4-keto-retinoic acid. Arch Biochem Biophys 199: 374–383
Rockley NL, Halley BA and Nelson EC (1980) Identification of a decarboxylation product of retinoic acid. Biochem Biophys Acta 627: 270–275
Sass JO, Forster A, Bock KW and Nau H (1994) Glucuronidation and isomerization of all-trans- and 13-cis-retinoic acid by liver microsomes of phenobarbital-or 3-methylcholanthrene-treated rats. Biochem Pharmacol 47: 485–492
Sonneveld E, van den Brink CE, van der Leede BM, Schulkes RK, Petkovich M, van der Burg B and van der Saag PT (1998) Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells. Cell Growth Differ 9: 629–637
Sun SY, Yue P, Dawson MI, Shroot B, Michel S, Lamph WW, Heyman RA, Teng M, Chandraratna RA, Shudo K, Hong WK and Lotan R (1997) Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. Cancer Res 57: 4931–4939
Teerlink T, Copper MP, Klaassen I and Braakhuis BJ (1997) Simultaneous analysis of retinol, all-trans-and 13-cis-retinoic acid and 13-cis-4-oxoretinoic acid in plasma by liquid chromatography using on-column concentration after single-phase fluid extraction. J Chromatogr B Biomed Sci Appl 694: 83–92
White JA, Beckett-Jones B, Guo YD, Dilworth FJ, Bonasoro J, Jones G and Petkovich M (1997) cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450. J Biol Chem 272: 18538–18541
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Klaassen, I., Brakenhoff, R., Smeets, S. et al. Metabolism and growth inhibition of four retinoids in head and neck squamous normal and malignant cells. Br J Cancer 85, 630–635 (2001). https://doi.org/10.1054/bjoc.2001.1952
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1952
Keywords
This article is cited by
-
Retinoic acid metabolism in cancer: potential feasibility of retinoic acid metabolism blocking therapy
Medical Molecular Morphology (2023)
-
Mechanism of inhibition of MMTV-neu and MMTV-wnt1 induced mammary oncogenesis by RARα agonist AM580
Oncogene (2010)